JD Supra8d
FDA Cosmetic Updates: New Q&As for MoCRA Facility Registration, Product Listing; Delayed Timelines for GMPs and More
FDA continues to construct its regulatory program for cosmetic products, albeit at a slower pace than the congressional timelines provided in ...
JD Supra6d
FDA Seeks Comments on Updates to MoCRA Guidance on Registration, Listing of Cosmetic Product Facilities
On December 11, 2024, the US Food and Drug Administration (FDA) updated its Guidance for Industry: Registration and Listing of Cosmetic ...
FiercePharma12d
FDA reaffirms decision to erase Eli Lilly's tirzepatide from shortage list, halting future flow of knockoffs
The FDA has doubled down on its decision to remove Eli Lilly’s tirzepatide from its list of products that are in shortage. | ...
greenmarketreport14d
MediPharm Labs sells Ontario facility for C$5.5M as part of streamlining plan
Kensana wants to use the facility and MediaPharm’s reach to develop an FDA-approved topical chronic wound treatment using ...
The National Law Review5d
FDA Seeks Comments on Updates to MoCRA Guidance on Registration, Listing of Cosmetic Product Facilities
You are responsible for reading, understanding, and agreeing to the National Law Review's (NLR’s) and the National Law Forum LLC's Terms of Use and Privacy Policy ...